Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06395935
Status:
RECRUITING
Last Update Posted:
2024-05-02
First Post:
2024-04-29
Brief Title:
Wecare Study in Gastric Cancer Survivors
Sponsor:
Gyeongsang National University Hospital
Organization:
Gyeongsang National University Hospital
Study Overview
Official Title:
A Multi-center Prospective Randomized Study to Evaluate the Usefulness of Applying the Chronic Side Effect Management Platform Wecare in Gastric Cancer Survivors
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The KOrean QUality of life in Stomach cancer patients Study group KOQUSS made a method KOQUSS-40 for assessing appropriately the quality of life of gastric cancer patients who have undergone gastrectomy and developed a digital platform Wecare based on KOQUSS-40 In this study we propose a randomized controlled trial to compare quality of life after gastrectomy in patients with and without smartphone app support
Detailed Description:
Smartphone apps have been gaining popularity in the delivery of lifestyle interventions in chronic disease management In patients with cancer randomized clinical trials have investigated the effect of smartphone-based interventions and reported improved quality of recovery and equal satisfaction with care compared with conventional in-person follow-up However there are no studies yet in which smartphone apps have evaluated the quality of life in patients after gastric cancer surgery
Surgery is the mainstay of gastric cancer treatment The proportion of patients with early gastric cancer and their survival rate of gastric cancer patients are increasing in East Asia thanks to the nationwide endoscopy screening program As the number of long-term survivors after gastric cancer surgery increases interest in the quality of life after surgery is also increasing After gastrectomy the remaining stomach volume is reduced or lost and the vagus nerve is damaged during the surgery which has various effects on the motor function and hormone secretion function of the stomach Patients experience postgastrectomy syndrome which includes lethargy decreased appetite early satiety weight loss abdominal distension gastroesophageal reflux symptoms diarrhea anemia and dumping syndrome In addition to these physical symptoms patients experience various symptoms and aftereffects after stomach cancer surgery including psychological reactions such as fear anxiety and depression and social problems such as avoidance of interpersonal relationships social isolation and difficulty returning to society
Surgery is the mainstay of gastric cancer treatment The proportion of patients with early gastric cancer and their survival rate of gastric cancer patients are increasing in East Asia thanks to the nationwide endoscopy screening program As the number of long-term survivors after gastric cancer surgery increases interest in the quality of life after surgery is also increasing After gastrectomy the remaining stomach volume is reduced or lost and the vagus nerve is damaged during the surgery which has various effects on the motor function and hormone secretion function of the stomach Patients experience postgastrectomy syndrome which includes lethargy decreased appetite early satiety weight loss abdominal distension gastroesophageal reflux symptoms diarrhea anemia and dumping syndrome In addition to these physical symptoms patients experience various symptoms and aftereffects after stomach cancer surgery including psychological reactions such as fear anxiety and depression and social problems such as avoidance of interpersonal relationships social isolation and difficulty returning to society
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None